Patent · US Active

Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologies

US9700603B2 · kind B2 · utility

1Cited by

3References

16Claims

0Family size

Assignee

Laboratoire Francais du Fractionnement et des Biotechnologies · FR

Inventors

Jean-Luc Plantier · Val-de-Reuil, FR
Meyer-Michel Samama · Paris, FR

Key dates

Filing date	Jan 8, 2014
Grant date	Jul 11, 2017
Priority date	—
Expiry date	Jan 8, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/96463
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of factor Xa in the prevention or treatment in a patient, in particular a human being or an animal, of haemorrhagic events induced by taking anticoagulants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.